Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
02/09/2018 02/12/2018 02/14/2018 02/15/2018 02/16/2018 Date
2458.05(c) 2437(c) 2474(c) 2440(c) 2425 Last
8 985 11 599 10 056 10 015 10 415 Volume
+0.12% -0.86% +1.52% -1.37% -0.61% Change
More quotes
Financials ( INR)
Sales 2018 30 735 M
EBIT 2018 4 689 M
Net income 2018 3 672 M
Finance 2018 6 371 M
Yield 2018 1,77%
Sales 2019 34 503 M
EBIT 2019 5 798 M
Net income 2019 4 443 M
Finance 2019 7 826 M
Yield 2019 1,99%
P/E ratio 2018 57,68
P/E ratio 2019 48,27
EV / Sales2018 6,51x
EV / Sales2019 5,76x
Capitalization 207 B
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
05/23Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
02/10Gilead`s Biktarvy wins megablockbuster HIV nod, and rival GlaxoSmithKline str..
AQ
02/09GLAXOSMITHKLINE : Glaxo fraud probe after bribing doctors to prescribe its drugs
AQ
02/08GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo sales and profits both rise
AQ
02/08GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo sales and profits both
AQ
02/07GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo reports 4Q loss
AQ
02/04GLAXOSMITHKLINE PHARMACEUTICALS : Pharma Ltd's Q3FY18 standalone net profit rise..
AQ
02/04GLAXOSMITHKLINE PHARMACEUTICALS : standalone net profit rises 69.39% in the Dece..
AQ
02/03GLAXOSMITHKLINE PHARMACEUTICALS : Pharma q3 net up 69%
AQ
01/25INVESTIGATORS AT GLAXOSMITHKLINE PLC : method development...
AQ
01/19GLAXOSMITHKLINE : UK-based drugmaker GlaxoSmithKline mulls Kenya staff cuts
AQ
More news
Sector news : Pharmaceuticals - NEC
02/16S&P 500 caps off strongest week in five years
RE
02/16ASTRAZENECA : U.S. FDA approves AstraZeneca's immunotherapy for lung cancer
RE
02/16NOVARTIS : readies to auction U.S. generic pills business - sources
RE
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
02/01Listen in to Deepak Parekh, Chairman of HDFC on the issue of Long Term Capita..
1
02/01Deepak Parekh, Chairman of HDFC says that it is a good beginning to recognise..
1
02/01Deepak Parekh, Chairman of HDFC says 3.3% fiscal deficit is realistic. #Budge..
3
02/01 – Finance Minister has done well in allocating resources. We need rural deve..
2
01/29? We've been feeding capital to HDFC Life, it's time to return: Deepak Parekh.. 
More tweets
Qtime:34
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Technical analysis trends GLAXOSMITHKLINE PHARMACEUT
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 11
Average target price 2 311  INR
Spread / Average Target -5,2%
EPS Revisions
Managers
NameTitle
Annaswamy Vaidheesh Managing Director & Executive Director
Deepak Shantilal Parekh Non-Executive Chairman
Puja Thakur Chief Financial Officer
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-2.40%3 247
JOHNSON & JOHNSON-7.19%352 552
NOVARTIS-3.37%224 301
PFIZER-2.84%212 857
ROCHE HOLDING LTD.-9.37%210 327
MERCK AND COMPANY-0.50%149 572